SHANGHAI ALLIST PHARMACEUTICALS INC has a total of 37 patent applications. It decreased the IP activity by 100.0%. Its first patent ever was published in 2006. It filed its patents most often in WIPO (World Intellectual Property Organization), China and EPO (European Patent Office). Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and environmental technology are SYMPHONY EVOLUTION INC, BAIR KENNETH W and OBSHCHESTVO S OGRANICHENNOJ OTVETSTVENNOSTYU FARMINTERPRAJSEZ.
# | Country | Total Patents | |
---|---|---|---|
#1 | WIPO (World Intellectual Property Organization) | 11 | |
#2 | China | 6 | |
#3 | EPO (European Patent Office) | 6 | |
#4 | United States | 6 | |
#5 | Canada | 5 | |
#6 | Republic of Korea | 2 | |
#7 | Japan | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry | |
#3 | Environmental technology |
# | Name | Total Patents |
---|---|---|
#1 | Guo Jianhui | 20 |
#2 | Luo Huibing | 14 |
#3 | Jiang Yong | 14 |
#4 | Zhou Huayong | 7 |
#5 | Kuang Rongren | 5 |
#6 | Wang Shuhui | 4 |
#7 | Wu Yong | 4 |
#8 | Zhang Xiaofang | 3 |
#9 | Wang Meng | 3 |
#10 | Zhang Qiang | 2 |
Publication | Filing date | Title |
---|---|---|
EP2248806A2 | Quinazoline derivatives as tyrosine kinase inhibitors |